Tag Archives: MASH

Wegovy Gets F.D.A. Approval for MASH  The New York Times Novo Nordisk shares pop after Wegovy receives U.S. approval for liver disease  CNBC Novo’s Wegovy becomes first GLP-1 drug approved for MASH  BioPharma Dive FDA Approves Novo Nordisk’s Wegovy for Liver Disease  The Wall Street Journal Wegovy News Pushes Novo Nordisk Stock Higher  Barron’s Source link

Novo Nordisk wins FDA label expansion for Wegovy against liver disease MASH  Seeking Alpha Novo Nordisk’s Wegovy gets accelerated US approval for liver disease MASH  Reuters Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis  PR Newswire Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH  Yahoo Finance Novo Nordisk’s obesity …

Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators on Friday to treat an increasingly common liver disease, adding to the list of conditions for which the blockbuster therapy is now approved.  The Food and Drug Administration granted accelerated approval to Wegovy for patients with metabolic dysfunction-associated steatohepatitis, or MASH, with moderate to advanced liver scarring. The decision was …

Novo Nordisk’s Wegovy gets accelerated US approval for liver disease MASH  Reuters Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis  PR Newswire Novo Nordisk’s obesity drug Wegovy cleared to treat MASH  statnews.com Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH  Yahoo Finance Novo Nordisk’s Wegovy Gets US Approval for …